Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-08-13Clinical Trial Update: ALPPS Versus PVE/PL [NA]
This clinical trial update compares ALPPS with PVE/PL for colorectal cancer with liver metastases; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer [Phase 3]
Phase 3 trial evaluating Avastin (bevacizumab) plus Xeloda (capecitabine) as maintenance therapy in metastatic colorectal cancer has complet…
-
CLINICAL_TRIALS trial_result · 2014-08-07Clinical Trial Update: A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin [Phase 2]
This is a Phase 2 trial update reporting results for Avastin (bevacizumab) combined with XELOX or FOLFOX in metastatic colorectal cancer pat…
-
CLINICAL_TRIALS trial_result · 2014-08-07Clinical Trial Update: Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib [Phase 2]
A Phase 2 study evaluating 7 days of celecoxib pretreatment in patients with surgically resected colorectal adenomas and carcinomas; the tri…
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors [Phase 2]
A Phase 2 trial comparing panitumumab plus mFOLFOX6 to bevacizumab plus mFOLFOX6 as first-line therapy for metastatic colorectal cancer with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening
This clinical trial update reports the completed results of the PRESEPT study, which evaluated the SEPT9 DNA methylation biomarker for color…
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: Specimens for Septin 9 Performance [EARLY_Phase 1]
A completed EARLY Phase 1 trial update describing specimens used to assess SEPT9 DNA methylation performance for colorectal cancer.
-
CLINICAL_TRIALS withdrawal · 2014-08-04Clinical Trial Update: Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test
The clinical trial assessing Septin9 biomarker for detection of colorectal cancer in FIT-positive patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Comparison of Methods to Distend the Colon During Insertion: CO2, Air Insufflation, Water-aided Colonoscopy [NA]
Completed clinical trial comparing CO2, air insufflation, and water-aided distension methods during colonoscopy insertion.
-
CLINICAL_TRIALS research · 2014-07-31Clinical Trial Update: Prevalence of the Mutational Status of V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) in Metastatic Colorectal Cancer (mCRC) in Argentine Patients
A completed clinical trial evaluating how common KRAS mutations are in Argentine patients with metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2014-07-30Clinical Trial Update: Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment [Phase 2]
A Phase II-b randomized trial of cabazitaxel in metastatic colorectal cancer resistant to standard treatment was terminated.
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: A Study of Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum [Phase 2]
Phase 2 study of Avastin (bevacizumab) combined with chemotherapy in metastatic colorectal cancer; results have been posted for a completed …
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Peer Patient Navigation for Colon Cancer Screening [NA]
This update reports the completion of a clinical trial evaluating peer patient navigation to improve colon cancer screening uptake using scr…
-
CLINICAL_TRIALS trial_result · 2014-07-23Clinical Trial Update: Intravenous BIBH 1 in Patients With Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial update for intravenous BIBH 1 in metastatic colorectal cancer; the study has completed.
-
FDA approval · 2014-07-22FDA Approved: XELODA — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for XELODA (capecitabine) from H2-Pharma, LLC. This notice confirms regulatory approval of a cha…
-
CLINICAL_TRIALS trial_result · 2014-07-22Clinical Trial Update: Narrow Band Imaging in the Prediction of Surveillance Intervals After Polypectomy in Community Practice: Ready for (a European) Prime Time
Completed clinical trial evaluating Narrow Band Imaging to predict surveillance intervals after polypectomy in community practice, aiming to…
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial evaluating high-dose cholecalciferol with chemotherapy and bevacizumab as first-line therapy for metastatic colorectal cancer …
-
CLINICAL_TRIALS withdrawal · 2014-07-21Clinical Trial Update: Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy [NA]
A clinical trial evaluating short-infusion ziv-aflibercept in combination chemotherapy for metastatic colorectal cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2014-07-16Clinical Trial Update: Differences in Timely Cancer Diagnosis in African American and Caucasian Patients With Newly Diagnosed Colorectal Cancer
The trial update discusses racial disparities in the timeliness of colorectal cancer diagnosis between African American and Caucasian patien…
-
CLINICAL_TRIALS research · 2014-07-14Clinical Trial Update: Effect of an Advanced Notification Letter on Screening Colonoscopy Participation [NA]
This update describes a clinical trial assessing whether an advanced notification letter affects participation in screening colonoscopy.
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin [Phase 2]
Phase 2 clinical trial update on GW572016 (lapatinib) for colorectal cancer patients who previously received 5-FU plus CPT-11 and/or oxalipl…
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: A Study of Mitomycin C, Irinotecan, and Cetuximab [Phase 2]
A Phase 2 study evaluating mitomycin C, irinotecan, and cetuximab for colorectal cancer was terminated, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial evaluating irinotecan, fluorouracil, and leucovorin with or without zibotentan for metastatic colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma. [Phase 2]
A completed Phase 2 trial assessed the safety and tolerability of the G17DT vaccine in patients with colorectal cancer (colorectal adenocarc…
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer [Phase 2]
A Phase 2 trial evaluating bevacizumab plus capecitabine as first-line therapy for older patients with metastatic colorectal cancer; the stu…